## Section 6: Safe Outputs and Review

###### 6.1 Outputs and Dissemination

This section details with the outputs from your analysis, how you propose to report your results and outcomes, and the controls in place to minimise any associated risks. Reporting and publication includes any dissemination or disclosure of any of the data and outputs from the proposal, to any person not already specifically identified in earlier questions, or who is not themselves one of the data subjects. This includes the dissemination or disclosure of any of the data sources or datasets, parts or components thereof detailed in the proposal, and of any results or outcomes, detailed, summarised, anonymised or otherwise, resulting from proposed processing of data. Dissemination or disclosure can take place in a variety of ways and through many mechanisms, including through electronic media, print media, or by word of mouth.

6.1.01 Please outline the procedure that will be used for disclosure control for the outcomes of the proposal. This is to ensure that tables and information from the findings does not include outputs from which any person could potentially be identified. Please pay particular attention to small groups, which should not consist of numbers less than 5. If you have groups containing <5 people, these should be combined so that the outputs contain groups >5. 6.1.02 Please indicate whether any of the outputs from the data will be published beyond those listed in section 1. Please note, if there is no dissemination this might raise some questions as to the public benefit of the proposal. If 'No', please go to section 6.2 6.1.03 Please indicate how the results and outcomes from the proposal will be published or disseminated to stakeholders and interested parties, including patients and the general public. As the public do not read scientific literature or attend conferences, you will need to consider how the results or outcomes will be disseminated to the wider public and how this fits with the public benefits of the proposal, as outlined in Q 3.1.08. Outputs to the public could include: press releases, social media, progress reports on websites that the public might access, feedback to patient groups. The public are interested in the outcomes of research. If the public or patient groups have had some input into the proposal in some way, or the work focuses on a particular patient group whose data has been used, it is only polite that they are informed about the outcomes of the work. 6.1.04 Please describe the steps you will take to ensure the confidentiality of the data when disseminating or publishing your outcomes. This may include the application of disclosure control procedures, aggregation of data or other approaches. 6.1.05 Please detail any circumstances where a living or dead individual may be cited in the dissemination of outputs from your proposal. 6.1.06 Please confirm if you have sought any permission from data controller or other bodies to publish any findings or outputs. If you have then please provide details of who has and what they have given permission to publish and append any approval correspondence.

#### 6.2 Retention and Disposal of data

This section details how the proposal will treat data being processed after it has been used for the purpose of the proposal outlined, including governance in place to determine how long it will be retained, and controls to manage its subsequent disposal. This section should show that you have considered these aspects of processing, and you will commit to appropriate retention and disposal of data. A comprehensive records management and / or retention policy will cover each of the aspects explored in this section; please